Otosclerosis Mechanisms and Cochlear Implantation Outcomes

Otosclerosis is a unique otic capsule dysregulation characterised by abnormal bone remodelling that progresses through an active “spongiotic” phase and a later sclerotic phase. Genetic predisposition interacts with local factors to produce areas of bone resorption and deposition around the oval and round windows. Lesions confined to the fenestrae cause conductive hearing loss, while extension into the cochlear capsule induces sensorineural or mixed deficits. Modern imaging modalities refine lesion characterisation and guide treatment: stapedectomy with prosthesis insertion restores ossicular continuity in fenestral disease, whereas retrofenestral involvement and profound sensorineural loss often require cochlear implantation. Pharmacological agents such as bisphosphonates have shown promise in stabilising sensorineural thresholds. Outcomes of cochlear implantation in otosclerosis are generally favourable, with specific inner ear anomalies—such as cavitary plaques or “third window” defects—being evaluated for their impact on implant performance. Advances in molecular genetics, imaging and surgical technique are converging to improve diagnostic precision and patient-centred management worldwide.

Research from Nature Portfolio

A large-scale genome-wide meta-analysis across several biobanks has uncovered over twenty novel loci associated with otosclerosis, highlighting genes integral to transforming growth factor beta signalling and bone mineralisation. Detailed developmental immunostaining in mouse otic capsules has revealed stage-specific expression patterns of key proteins, elucidating temporal regulation of bone remodelling within the labyrinthine capsule. These insights pave the way for targeted therapeutic strategies aimed at modulating the aberrant remodelling process.

Otosclerosis Mechanisms and Cochlear Implantation Outcomes publication trend

The graph below shows the total number of articles in otosclerosis mechanisms and cochlear implantation outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Otic capsule: The dense bony structure encasing the inner ear labyrinth and the primary site of otosclerotic change.

Otosclerosis: A pathological process of bone resorption and formation in the otic capsule resulting in hearing impairment.

Fenestral otosclerosis: Disease localised to the oval window region, typically causing conductive hearing loss.

Retrofenestral otosclerosis: Extension of disease into the cochlear capsule, leading to mixed or sensorineural hearing loss.

Cochlear implantation: The surgical placement of an electronic device within the cochlea to restore auditory perception in severe to profound hearing loss.

Cavitary plaque: A focal, cavitating lesion within otospongiotic bone that may alter inner ear mechanics but does not necessarily complicate implantation.

Third window effect: An abnormal bony defect creating an additional mobile window in the inner ear, potentially dissipating sound energy and affecting auditory outcomes.

References

1. Genome-wide screen of otosclerosis in population biobanks: 27 loci and shared associations with skeletal structure. Nature Communications (2023).
2. Comparative study of the sensitivity of ultra-high-resolution CT and high-resolution CT in the diagnosis of isolated fenestral otosclerosis. Insights into Imaging (2023).
3. Imaging in otosclerosis: A pictorial review. Insights into Imaging (2014).
4. Cavitary Plaques in Otospongiosis: CT Findings and Clinical Implications. American Journal of Neuroradiology (2018).
5. Third‐generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long‐term follow‐up. Laryngoscope Investigative Otolaryngology (2017).
6. “Third Window” and “Single Window” Effects Impede Surgical Success: Analysis of Retrofenestral Otosclerosis Involving the Internal Auditory Canal or Round Window. Journal of Clinical Medicine (2019).